Lv5
1050 积分 2025-05-06 加入
Plaque‐Hepatic Targeting Nanotherapy Disrupts the PCSK9‐LOX‐1 Axis to Suppress oxLDL in Atherosclerosis
2天前
已完结
Asprosin‐FABP5 Interaction Modulates Mitochondrial Fatty Acid Oxidation through PPARα Contributing to MASLD Development
10天前
已完结
An odorant-binding protein functions in fire ant social immunity interfacing with innate immunity
1个月前
已完结
A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment
1个月前
已完结
ROS-responsive biomimetic nanovesicles to plaque microenvironment in targeted therapy of atherosclerosis
1个月前
已完结
Ros-responsive nano-platform for lipid-specific fluorescence imaging of atherosclerosis
1个月前
已完结
ROS-responsive bionanodrug for atherosclerosis therapy via regulating glycolipid metabolism and cell crosstalk
1个月前
已关闭
Nanoparticle Drug Delivery Systems for Atherosclerosis: Precision Targeting, Inflammatory Modulation, and Plaque Stabilization
1个月前
已完结
Atherosclerosis
1个月前
已完结
Self-assembled lipid–prodrug nanoparticles
1个月前
已完结
皖公网安备34019202002308
